|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 26
Zeitschriftenartikel
Mertsch, Pontus; Götschke, Jeremias; Walter, Julia; Mümmler, Carlo; Ghiani, Alessandro; Schürmann, Ulrike; Kiefl, Rosemarie; Huber, Rudolf Maria; Behr, Jürgen; Kneidinger, Nikolaus und Milger, Katrin
(2022):
Response to high-altitude triggers in seasonal asthmatics on and off inhaled corticosteroid treatment.
In: World Allergy Organization Journal, Bd. 15, Nr. 10
[PDF, 690kB]
Tufman, Amanda; Neumann, Jens; Manapov, Farkhad; Sellmer, Laura; Jung, Andreas; Kauffmann-Guerrero, Diego; Kahnert, Kathrin; Mertsch, Pontus; Borgmeier, Astrid; Semrau, Sabine; Rittmeyer, Achim; Ulm, Bernhard; Ulm, Kurt; Flentje, Michael; Fietkau, Rainer und Huber, Rudolf Maria
(2021):
Prognostic and predictive value of PD-L1 expression and tumour infiltrating lymphocytes (TiLs) in locally advanced NSCLC treated with simultaneous radiochemotherapy in the randomized, multicenter, phase III German Intergroup lung Trial (GILT).
In: Lung Cancer, Bd. 160: S. 17-27
Schunk, Michaela; Le, Lien; Syunyaeva, Zulfiya; Haberland, Birgit; Taenzler, Susanne; Mansmann, Ulrich; Schwarzkopf, Larissa; Seidl, Hildegard; Streitwieser, Sabine; Hofmann, Miriam; Mueller, Thomas; Weiss, Tobias; Morawietz, Philipp; Rehfuess, Eva Annette; Huber, Rudolf Maria; Berger, Ursula und Bausewein, Claudia
(2021):
Effectiveness of a specialised breathlessness service for patients with advanced disease in Germany: a pragmatic fast-track randomised controlled trial (BreathEase).
In: European Respiratory Journal, Bd. 58, Nr. 2, 2002139
Schunk, Michaela; Berger, Ursula; Le, Lien; Rehfuess, Eva; Schwarzkopf, Larissa; Streitwieser, Sabine; Mueller, Thomas; Hofmann, Miriam; Holle, Rolf; Huber, Rudolf Maria; Mansmann, Ulrich und Bausewein, Claudia
(2021):
BreathEase: rationale, design and recruitment of a randomised trial and embedded mixed-methods study of a multiprofessional breathlessness service in early palliative care.
In: Erj Open Research, Bd. 7, Nr. 4, 228
Schunk, Michaela; Berger, Ursula; Le, Lien; Rehfuess, Eva Annette; Schwarzkopf, Larissa; Streitwieser, Sabine; Müller, Thomas; Hofmann, Miriam; Holle, Rolf; Huber, Rudolf Maria; Mansmann, Ulrich 
ORCID: https://orcid.org/0000-0002-9955-8906 und Bausewein, Claudia ORCID: https://orcid.org/0000-0002-0958-3041
(2021):
BreathEase: rationale, design and recruitment of a randomised trial and embedded mixed-methods study of a multiprofessional breathlessness service in early palliative care.
In: ERJ Open Research, Bd. 7, Nr. 4
[PDF, 731kB]
ORCID: https://orcid.org/0000-0002-9955-8906 und Bausewein, Claudia ORCID: https://orcid.org/0000-0002-0958-3041
(2021):
BreathEase: rationale, design and recruitment of a randomised trial and embedded mixed-methods study of a multiprofessional breathlessness service in early palliative care.
In: ERJ Open Research, Bd. 7, Nr. 4
[PDF, 731kB]
Schunk, Michaela; Le, Lien; Syunyaeva, Zulfiya; Haberland, Birgit; Tänzler, Susanne; Mansmann, Ulrich ORCID: https://orcid.org/0000-0002-9955-8906; Schwarzkopf, Larissa; Seidl, Hildegard; Streitwieser, Sabine; Hofmann, Miriam; Müller, Thomas; Weiß, Tobias; Morawietz, Philipp; Rehfuess, Eva Annette; Huber, Rudolf Maria; Berger, Ursula und Bausewein, Claudia ORCID: https://orcid.org/0000-0002-0958-3041
(2021):
Effectiveness of a specialised breathlessness service for patients with advanced disease in Germany. A pragmatic fast track randomised controlled trial (BreathEase).
In: The European Respiratory Journal, Bd. 57, Nr. 2
ORCID: https://orcid.org/0000-0002-9955-8906; Schwarzkopf, Larissa; Seidl, Hildegard; Streitwieser, Sabine; Hofmann, Miriam; Müller, Thomas; Weiß, Tobias; Morawietz, Philipp; Rehfuess, Eva Annette; Huber, Rudolf Maria; Berger, Ursula und Bausewein, Claudia ORCID: https://orcid.org/0000-0002-0958-3041
(2021):
Effectiveness of a specialised breathlessness service for patients with advanced disease in Germany. A pragmatic fast track randomised controlled trial (BreathEase).
In: The European Respiratory Journal, Bd. 57, Nr. 2
Kauffmann-Guerrero, Diego ORCID: https://orcid.org/0000-0003-1471-3290 und Huber, Rudolf Maria
(2020):
Orphan Drugs in Development for the Treatment of Small-Cell Lung Cancer: Emerging Data on Lurbinectedin.
In: Lung Cancer-Targets and Therapy, Bd. 11: S. 27-31
[PDF, 434kB]
ORCID: https://orcid.org/0000-0003-1471-3290 und Huber, Rudolf Maria
(2020):
Orphan Drugs in Development for the Treatment of Small-Cell Lung Cancer: Emerging Data on Lurbinectedin.
In: Lung Cancer-Targets and Therapy, Bd. 11: S. 27-31
[PDF, 434kB]
Wessels, Sabine; Muley, Thomas; Christopoulos, Petros; Meister, Michael; Heinzmann-Groth, Ingrid; Warth, Arne; Herpel, Esther; Hummler, Simone; Klingmüller, Ursula; Kuon, Jonas; Heussel, Claus-Peter; Eberhardt, Ralf; Herth, Felix J. F.; Winter, Hauke; Bischoff, Helge; Stenzinger, Albrecht; Reck, Martin; Huber, Rudolf Maria; Thomas, Michael und Schneider, Marc A.
(2020):
Comprehensive serial biobanking in advanced NSCLC: feasibility, challenges and perspectives.
In: Translational Lung Cancer Research, Bd. 9, Nr. 4: S. 1000-1014
Kauffmann-Guerrero, Diego; Schindler, Andreas; Tufman, Amanda; Syunyaeva, Zulfiya; Pfluger, Thomas; Huber, Rudolf Maria; Berger, Frank und Kahnert, Kathrin
(2019):
Response assessment in non-small cell lung cancer immunotherapy: initial experiences in utilizing FDG PET/CT and the PD-1 blocker nivolumab.
In: Memo-Magazine of European Medical Oncology, Bd. 12, Nr. 2: S. 149-155
Roengvoraphoj, Olarn; Wijaya, Cherylina; Eze, Chukwuka; Li, Minglun; Dantes, Maurice; Taugner, Julian; Tufman, Amanda; Huber, Rudolf Maria; Belka, Claus und Manapov, Farkhad
(2018):
Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer.
In: Strahlentherapie und Onkologie, Bd. 194, Nr. 2: S. 107-115
Kauffmann-Guerrero, Diego; Huber, Rudolf Maria; Reu, Simone; Tufman, Amanda; Mertsch, Pontus; Syunyaeva, Zulfiya; Jung, Andreas und Kahnert, Kathrin
(2018):
NSCLC Patients Harbouring Rare or Complex EGFR Mutations Are More Often Smokers and Might Not Benefit from First-Line Tyrosine Kinase Inhibitor Therapy.
In: Respiration, Bd. 95, Nr. 3: S. 169-176
Roengvoraphoj, Olarn; Eze, Chukwuka; Wijaya, Cherylina; Dantes, Maurice; Taugner, Julian; Tufman, Amanda; Huber, Rudolf Maria; Bartenstein, Peter; Belka, Claus und Manapov, Farkhad
(2018):
How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 45, Nr. 12: S. 2103-2109
Götschke, Jeremias; Mertsch, Pontus; Kneidinger, Nikolaus; Kauffmann-Guerrero, Diego; Behr, Jürgen; Huber, Rudolf Maria; Reichenberger, Frank und Milger, Katrin
(2018):
Daily Chronic Intermittent Hypobaric Hypoxia Does Not Induce Chronic Increase in Pulmonary Arterial Pressure Assessed by Echocardiography.
In: Canadian Respiratory Journal, Bd. 2018, 9649716
[PDF, 589kB]
Rich, Anna; Baldwin, David; Alfageme, Inmaculada; Beckett, Paul; Berghmans, Thierry; Brincat, Stephen; Burghuber, Otto; Corlateanu, Alexandru; Cufer, Tanja; Damhuis, Ronald; Danila, Edvardas; Domagala-Kulawik, Joanna; Elia, Stefano; Gaga, Mina; Goksel, Tuncay; Grigoriu, Bogdan; Hillerdal, Gunnar; Huber, Rudolf Maria; Jakobsen, Erik; Jonsson, Steinn; Jovanovic, Dragana; Kavcova, Elena; Konsoulova, Assia; Laisaar, Tanel; Makitaro, Riitta; Mehic, Bakir; Milroy, Robert; Moldvay, Judit; Morgan, Ross; Nanushi, Milda; Paesmans, Marianne; Putora, Paul Martin; Samarzija, Miroslav; Scherpereel, Arnaud; Schlesser, Marc; Sculier, Jean-Paul; Skrickova, Jana; Sotto-Mayor, Renato; Strand, Trond-Eirik; Schil, Paul van und Blum, Torsten-Gerriet
(2018):
Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries.
In: BMC Cancer
18:1144
[PDF, 717kB]
Brückl, Wolfgang; Tufman, Amanda und Huber, Rudolf Maria
(2017):
Advanced non-small cell lung cancer (NSCLC) with activating EGFR mutations: first-line treatment with afatinib and other EGFR TKIs.
In: Expert Review of Anticancer therapy, Bd. 17, Nr. 2: S. 143-155
Meyer, Mathias; Vliegenthart, Rozemarijn; Henzler, Thomas; Buergy, Daniel; Giordano, Frank A.; Kostrzewa, Michael; Rathmann, Nils; Brustugun, Odd Terje; Crino, Lucio; Dingemans, Anne-Marie C.; Dusmet, Michael; Fennell, Dean; Grunenwald, Dominique; Huber, Rudolf Maria; Moniuszko, Marcin; Mornex, Francoise; Papotti, Mauro; Pilz, Lothar; Senan, Suresh; Syrigos, Kostas; Perol, Maurice; Gray, Jhanelle E.; Schabel, Christoph; Meerbeeck, Jan R. van; Zandwijk, Nico van; Zhou, Cai Cun; Manegold, Christian; Voigt, Wieland und Rössner, Eric Dominic
(2017):
Management of Progressive Pulmonary Nodules Found during and outside of CT Lung Cancer Screening Studies.
In: Journal of thoracic Oncology, Bd. 12, Nr. 12: S. 1755-1765
Gütz, Sylvia; Tufman, Amanda; Pawel, Joachim von; Rittmeyer, Achim; Borgmeier, Astrid; Ferre, Pierre; Edlich, Birgit und Huber, Rudolf Maria
(2017):
Metronomic treatment of advanced non-small-cell lung cancer with daily oral vinorelbine - a Phase I trial.
In: Oncotargets and therapy, Bd. 10: S. 1081-1089
[PDF, 679kB]
Kauffmann-Guerrero, Diego; Kahnert, Kathrin; Pratschke, Sebastian; Angstwurm, Matthias; Tufman, Amanda und Huber, Rudolf Maria
(2017):
Black and Blue.
In: Respiration, Bd. 94, Nr. 5: S. 465-466
Tufman, Amanda; Kahnert, Kathrin; Kauffmann-Guerrero, Diego; Manapov, Farkhad; Milger, Katrin; Müller-Lisse, Ullrich; Winter, Hauke; Huber, Rudolf Maria und Schneider, Christian
(2017):
Clinical relevance of the M1b and M1c descriptors from the proposed TNM 8 classification of lung cancer.
In: Strahlentherapie und Onkologie, Bd. 193, Nr. 5: S. 392-401
Tufman, Amanda; Kahnert, Kathrin; Duell, Thomas; Kauffmann-Guerrero, Diego; Milger, Katrin; Schneider, Christian; Stump, Julia; Syunyaeva, Zulfiya; Huber, Rudolf Maria und Reu, Simone
(2017):
Frequency and clinical relevance of EGFR mutations and EML4-ALK translocations in octogenarians with non-small cell lung cancer.
In: Oncotargets and therapy, Bd. 10: S. 5179-5186
[PDF, 535kB]
Kahnert, Kathrin; Kauffmann-Guerrero, Diego und Huber, Rudolf Maria
(2016):
SCLC-State of the Art and What Does the Future Have in Store?
In: Clinical Lung Cancer, Bd. 17, Nr. 5: S. 325-333
Tufman, Amanda; Huber, Rudolf Maria; Volk, Stefanie; Aigner, Frederic; Edelmann, Martin; Gamarra, Fernando; Kiefl, Rosemarie; Kahnert, Kathrin; Tian, Fei; Boulesteix, Anne-Laure; Endres, Stefan und Kobold, Sebastian
(2016):
Interleukin-22 is elevated in lavage from patients with lung cancer and other pulmonary diseases.
In: BMC Cancer, Bd. 16: S. 409
Milger, Katrin; Holdt, Lesca Miriam; Teupser, Daniel; Huber, Rudolf Maria; Behr, Jürgen und Kneidinger, Nikolaus
(2015):
Identification of a novel SERPINA-1 mutation causing alpha-1 antitrypsin deficiency in a patient with severe bronchiectasis and pulmonary embolism.
In: International Journal of Chronic Obstructive Pulmonary Disease, Bd. 10: S. 891-897
[PDF, 1MB]
Specht, Hanno M.; Ahrens, Norbert; Blankenstein, Christiane; Duell, Thomas; Fietkau, Rainer; Gaipl, Udo S.; Günther, Christine; Gunther, Sophie; Habl, Gregor; Hautmann, Hubert; Hautmann, Matthias; Huber, Rudolf Maria; Molls, Michael; Offner, Robert; Rödel, Claus; Rödel, Franz; Schütz, Martin; Combs, Stephanie E. und Multhoff, Gabriele
(2015):
Heat shock protein 70 (Hsp70) peptide activated Natural Killer (NK) cells for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCTx) - from preclinical studies to a clinical phase II trial.
In: Frontiers in Immunology, Bd. 6, UNSP 162
[PDF, 812kB]
Schrödl, Kathrin; Schilling, Christoph von; Tufman, Amanda; Huber, Rudolf Maria und Gamarra, Fernando
(2014):
Response to chemotherapy, reexposure to crizotinib and treatment with a novel ALK inhibitor in a patient with acquired crizotinib resistance.
In: Respiration, Bd. 88, Nr. 3: S. 262-264
[PDF, 65kB]
Kobold, Sebastian; Völk, Stefanie; Clauditz, Till; Küpper, Natascha Jennifer; Minner, Sarah; Tufman, Amanda; Düwell, Peter; Lindner, Michael; Koch, Ina; Heidegger, Simon; Rothenfußer, Simon; Schnurr, Max; Huber, Rudolf Maria; Wilczak, Waldemar und Endres, Stefan
(August 2013):
Interleukin-22 Is Frequently Expressed in Small- and Large-Cell Lung Cancer and Promotes Growth in Chemotherapy-Resistant Cancer Cells.
In: Journal of Thoracic Oncology, Bd. 8, Nr. 8: S. 1032-1042
[PDF, 1MB]